10.40Open10.40Pre Close1 Volume0 Open Interest67.00Strike Price1.04KTurnover2887.22%IV0.27%PremiumDec 13, 2024Expiry Date10.19Intrinsic Value100Multiplier-1DDays to Expiry0.21Extrinsic Value100Contract SizeAmericanOptions Type0.9962Delta0.0028Gamma7.76Leverage Ratio-16.0630Theta0.0000Rho7.73Eff Leverage0.0000Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet